Preferential expression of cancer/testis genes in cancer stem-like cells: Proposal of a novel sub-category, cancer/testis/stem gene

Tissue Antigens

Volumn 81, Issue 6, 2013, Pages 428-434

  Yamada, R ^a   Takahashi, A ^a   Torigoe, T ^a   Morita, R ^a   Tamura, Y ^a   Tsukahara, T ^a   Kanaseki, T ^a   Kubo, T ^a   Watarai, K ^a   Kondo, T ^b   Hirohashi, Y ^a   Sato, N ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cell; Cancer testis gene; Cancer testis stem gene

Indexed keywords

CANCER TESTIS ANTIGEN; PROTEIN; PROTEIN BAGE 1; PROTEIN BAGE 2; PROTEIN BAGE 4; PROTEIN BAGE 5; PROTEIN BORIS; PROTEIN CT4A 1; PROTEIN GAGE 1; PROTEIN GAGE 8; PROTEIN HCA 661; PROTEIN LIP 1; PROTEIN MAGEA 12; PROTEIN MAGEA 2; PROTEIN MAGEA 3; PROTEIN MAGEA 4; PROTEIN MAGEA 6; PROTEIN PLU 1; PROTEIN SGY 1; PROTEIN SPA 17; PROTEIN SPANXA 1; PROTEIN SPANXB 1; PROTEIN SPANXC; PROTEIN TDRD 1; PROTEIN TEX 15; PROTEIN TPTE; PROTEIN XAGE 2; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER STEM CELL; CELL STRAIN MCF 7; COLON ADENOCARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE POPULATION CELL;

ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MCF-7 CELLS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; SPERMATOGENESIS; TESTIS;

EID: 84877636710     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12113     Document Type: Article

References (23)

1. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991: 254: 1643-7.
2. Hirohashi Y, Torigoe T, Inoda S et al. The functioning antigens: beyond just as the immunological targets. Cancer Sci 2009: 100: 798-806.
3. Boon T, Coulie PG, Van den Eynde B. Tumor antigens recognized by T cells. Immunol Today 1997: 18: 267-8.
4. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immunol 2004: 4: 1.
5. Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006: 66: 9339-44.
6. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005: 5: 275-84.
7. Todaro M, D'Asaro M, Caccamo N et al. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 2009: 182: 7287-96.
8. Castriconi R, Daga A, Dondero A et al. NK cells recognize and kill human glioblastoma cells with stem cell-like properties. J Immunol 2009: 182: 3530-9.
9. Inoda S, Hirohashi Y, Torigoe T et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am J Pathol 2011: 178: 1805-13.
10. Hirohashi Y, Torigoe T, Inoda S et al. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2010: 2: 201-11.
11. Nishizawa S, Hirohashi Y, Torigoe T et al. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 2012: 72: 2844-54.
12. Hirohashi Y, Torigoe T, Hirai I et al. Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells. Exp Mol Pathol 2010: 88: 128-32.
13. Nakatsugawa M, Takahashi A, Hirohashi Y et al. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Lab Invest 2011: 91: 1796-804.
14. Nakatsugawa M, Hirohashi Y, Torigoe T et al. Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4. Cancer Sci 2009: 100: 1485-93.
15. Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 2008: 68: 2419-26.
16. Cheng YH, Wong EW, Cheng CY. Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis. Spermatogenesis 2011: 1: 209-20.
17. Fratta E, Coral S, Covre A et al. The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol Oncol 2011: 5: 164-82.
18. Sang M, Lian Y, Zhou X, Shan B. MAGE-A family: attractive targets for cancer immunotherapy. Vaccine 2011: 29: 8496-500.
19. Nishikawa H, Maeda Y, Ishida T et al. Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. Blood 2012: 119: 3097-104.
20. Graff-Dubois S, Faure O, Gross DA et al. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy. J Immunol 2002: 169: 575-80.
21. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995: 182: 689-98.
22. Hirohashi Y, Torigoe T, Inoda S, Morita R, Kochin V, Sato N. Cytotoxic T lymphocytes: sniping cancer stem cells. Oncoimmunology 2012: 1: 123-5.
23. Mori T, Nishizawa S, Hirohashi Y et al. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population. Exp Mol Pathol 2012: 92: 27-32.